Smartwatches in the digital health ecosystem for health monitoring in patients with chronic kidney disease and kidney failure: opportunities and challenges

Smartwatches are widely used by the general population as tools to promote wellness. Modern smartwatches can monitor arterial oxygen saturation, blood pressure, heart rate, arrhythmias, physical activity, sleep patterns, falls and body composition. In individuals with chronic illnesses, smartwatches may support improved self-care and patient empowerment, support advanced phenotyping by providing digital biomarkers, enable early detection of clinically relevant changes in physiological parameters, and facilitate remote patient monitoring. Patients with chronic kidney disease, particularly those with kidney failure, often experience multiple abnormalities in physiological parameters and body functions. These disturbances may go undetected during routine clinical visits or HD treatments, yet they can significantly impact outcomes and may be amendable through therapeutic interventions. Especially when integrated with data from electronic health records and medical devices such as HD machines, smartwatches may be part of a digital ecosystem, supporting personalized precision care and patient empowerment. However, use of smartwatches in healthcare also can produce false positive signals, which can lead to patient anxiety and potentially increase healthcare utilization and contribute to digital inequity. At present, their potential and challenges of smartwatches in kidney disease are largely unexplored. To fill this gap, this review aims to provide a comprehensive overview of smartwatch-based applications in health monitoring, highlighting both opportunities and limitations in patients with chronic kidney disease and kidney failure. Despite promises for future healthcare implementation, the lack of validation studies for clinical grade measurements presently still precludes the use of smartwatches for clinical decision making.

Authors

Institutions

Publication Details

Journal
American Journal of Physiology-Renal Physiology
Published
2026-07-23
DOI
https://doi.org/10.1152/ajprenal.00434.2025
Primary Topic
Mobile Health and mHealth Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Smartwatches in the digital health ecosystem for health monitoring in patients with chronic kidney disease and kidney failure: opportunities and challenges

Peter Kotanko, Joris I. Rotmans, Sabine Josemans, Jeroen Kooman et al.
American Journal of Physiology-Renal Physiology
Mobile Health and mHealth Applications
article

Smartwatches in the digital health ecosystem for health monitoring in patients with chronic kidney disease and kidney failure: opportunities and challenges

Peter Kotanko, Joris I. Rotmans, Sabine Josemans, Jeroen Kooman, Len Usvyat, Maggie Han, Bernard Canaud
article en

Abstract

Smartwatches are widely used by the general population as tools to promote wellness. Modern smartwatches can monitor arterial oxygen saturation, blood pressure, heart rate, arrhythmias, physical activity, sleep patterns, falls and body composition. In individuals with chronic illnesses, smartwatches may support improved self-care and patient empowerment, support advanced phenotyping by providing digital biomarkers, enable early detection of clinically relevant changes in physiological parameters, and facilitate remote patient monitoring. Patients with chronic kidney disease, particularly those with kidney failure, often experience multiple abnormalities in physiological parameters and body functions. These disturbances may go undetected during routine clinical visits or HD treatments, yet they can significantly impact outcomes and may be amendable through therapeutic interventions. Especially when integrated with data from electronic health records and medical devices such as HD machines, smartwatches may be part of a digital ecosystem, supporting personalized precision care and patient empowerment. However, use of smartwatches in healthcare also can produce false positive signals, which can lead to patient anxiety and potentially increase healthcare utilization and contribute to digital inequity. At present, their potential and challenges of smartwatches in kidney disease are largely unexplored. To fill this gap, this review aims to provide a comprehensive overview of smartwatch-based applications in health monitoring, highlighting both opportunities and limitations in patients with chronic kidney disease and kidney failure. Despite promises for future healthcare implementation, the lack of validation studies for clinical grade measurements presently still precludes the use of smartwatches for clinical decision making.

American Journal of Physiology-Renal Physiology
Université de Montpellier (FR), Leiden University Medical Center (NL), Maastricht University (NL), Renal Research Institute (US), Fresenius Medical Care (United States) (US), Montpellier Business School (FR), Fresenius Medical Care North America (United States) (US)
Peace, Justice and strong institutions
Openalex Percentile: Top 6%
Mobile Health and mHealth Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.